Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan-You Liao

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancers|February 13, 2025
Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination TherapeuticsYan-You Liao, Chia-Luen Tsai, Hsiang-Po Huang
Cancers|August 26, 2022
HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal CancerYi-Jung Huang, Yi-Ting Chen, Chun-Ming Huang, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancers|February 13, 2025
Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination TherapeuticsYan-You Liao, Chia-Luen Tsai, Hsiang-Po Huang
Cancers|August 26, 2022
HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal CancerYi-Jung Huang, Yi-Ting Chen, Chun-Ming Huang, et al.
Pageof 1